Monitoring orbicularis oculi predicts good intubating conditions after vecuronium in children

Canadian Journal of Anaesthesia

Volumn 44, Issue 7, 1997, Pages 712-716

  Plaud, Benoît ^b   Laffon, Marc ^b   Ecoffey, Claude ^a   Meistelman, Claude ^b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VECURONIUM;

ARTICLE; GENERAL ANESTHESIA; HUMAN; NEUROMUSCULAR BLOCKING; ORBICULARIS OCULI MUSCLE; PATIENT MONITORING; PRIORITY JOURNAL; RESPIRATORY TRACT INTUBATION;

EID: 0030696086     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03013383     Document Type: Article

References (15)

1. Bencini A, Newton DEF. Rate of onset of good intubating conditions, respiratory depression and hand muscle paralysis after vecuronium. Br J Anaesth 1984; 56: 959-65.
2. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles. Anesthesiology 1990; 73: 870-5.
3. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. Anesthesiology 1991; 74: 833-7.
4. Ungureanu D, Meistelman C, Frossard J, Donati F. The orbicularis oculi and the adductor pollicis muscles as monitors of atracurium block of laryngeal muscles. Anesth Analg 1993; 77: 775-9.
5. Debaene B, Beaussier M, Meistelman C, Donati F, Lienhart A. Monitoring the onset of neuromuscular block at the orbicularis oculi can predict good intubating conditions during atracurium-induced neuromuscular block. Anesth Analg 1995; 80: 360-3.
6. Krieg N, Mazur L, Booij LHDJ, Crull JF. Intubating conditions and reversibility of a new non-depolarizing neuromuscular blocking agent, Org-NC45. Acta Anaesthesiol Scand 1980; 24: 423-5.
7. Laycock JRD, Baxter MK, Sevan JC, Sangwan S, Donati F, Bevan DR. The potency of pancuronium at the adductor pollicis and diaphragm in infants and children. Anesthesiology 1988; 68: 908-11.
8. Donati F. Pharmacokinetic and pharmacodynamic factors in the clinical use of muscle relaxants. Seminars in Anesthesia 1994; 13: 310-20.
9. Goudsouzian NG, Martyn JJA, Liu LMP, Gionfriddo M. Safety and efficacy of vecuronium in adolescents and children. Anesth Analg 1983; 62: 1083-8.
10. Meistelman C, Loose JP, Saint-Maurice C, Delleur MM, Da Silva GL. Clinical pharmacology of vecuronium in children. Studies during nitrous oxide and halothane in oxygen anaesthesia. Br J Anaesth 1986; 58: 996-1000.
11. Meretoja OA, Wirtavuori K, Neuvonen PJ. Age-dependence of the dose-response curve of vecuronium in pediatric patients during balanced anesthesia. Anesth Analg 1988; 67: 21-6.
12. 2O, halothane anesthesia. Anesthesiology 1983; 58: 519-23.
13. O'Hara DA, Fragen RJ, Shanks CA. Comparison of visual and measured train-of-four recovery after vecuronium-induced neuromuscular blockade using two anaesthetic techniques. Br J Anaesth 1986; 58: 1300-02.
14. Coté CJ, Goudsouzian NG, Liu LMP, Dedrick DF, Rosow CE. The dose response of intravenous thiopental for the induction of general anesthesia in unpremedicated children. Anesthesiology 1981; 55: 703-5.
15. Jonmarker C, Westrin P, Larsson S, Werner O. Thiopental requirements for induction of anesthesia in children. Anesthesiology 1987; 67: 104-7.